Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Nov 15, 2020; 12(11): 1272-1287
Published online Nov 15, 2020. doi: 10.4251/wjgo.v12.i11.1272
Published online Nov 15, 2020. doi: 10.4251/wjgo.v12.i11.1272
Figure 1 Clinical value of long non-coding RNA C9orf139 in patients with pancreatic cancer.
A: Relative serum expression of long non-coding RNA (lncRNA) C9orf139 in the patient group and control group; B: Expression of lncRNA C9orf139 in cancer tissues and adjacent tissues; C: Receiver operating characteristic curve of lncRNA C9orf139 for the diagnosis of pancreatic cancer; D: The 5-year survival of patients was higher in the low expression group than in the high expression group. eP < 0.001 for the comparison between two groups.
- Citation: Ge JN, Yan D, Ge CL, Wei MJ. LncRNA C9orf139 can regulate the growth of pancreatic cancer by mediating the miR-663a/Sox12 axis. World J Gastrointest Oncol 2020; 12(11): 1272-1287
- URL: https://www.wjgnet.com/1948-5204/full/v12/i11/1272.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i11.1272